Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-964-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames Test: negative
HPRT Assay: negative
Micronucleus Assay: negative
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018-09-07 to 2018-12-05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Version / remarks:
- 1998
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ICH Guideline S2 (R1): Genotoxicity testing and data interpretation for pharmaceuticals intended for human use,
- Version / remarks:
- 2012
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Species / strain / cell type:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Metabolic activation system:
- phenobarbital and beta-naphthoflavone induced rat liver S9
- Test concentrations with justification for top dose:
- Initial and confirmatory test I
±S9: 5000; 1600; 500; 160; 50 and 16 μg/plate
Confirmatory test II
-S9: 16, 5, 1.6, 0.5, 0.16 and 0.05 µg/plate - Vehicle / solvent:
- - Vehicle/solvent used:
test item: acetone
positive controls: water or DMSO
- Justification for choice of solvent/vehicle: The test item solutions were prepared in acetone and diluted prior to treatment. This vehicle was compatible with the survival of the bacteria and the S9 activity and was chosen based on the results of the preliminary solubility test. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- sodium azide
- methylmethanesulfonate
- other: 4-Nitro-1,2-phenylenediamine (NPD) 4 µg/plate, -S9, TA98; 2-aminoanthracene (2AA) 2 or 50 µg/plate for all salmonella strains or E.coli, +S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation); preincubation
DURATION
- Preincubation period: 20 min
- Exposure duration: 48 h in the dark
SELECTION AGENT: his and trp gene
NUMBER OF REPLICATIONS: 3
DETERMINATION OF CYTOTOXICITY
- Method: background lawn - Evaluation criteria:
- A test item is considered mutagenic if:
- a dose-related increase in the number of revertants occurs and/or;
- a reproducible biologically relevant positive response for at least one of the dose groups occurs in at least one strain with or without metabolic activation.
An increase is considered biologically relevant if:
- in strain Salmonella typhimurium TA100 the number of reversions is at least twice as high as the reversion rate of the vehicle control
- in strain Salmonella typhimurium TA98, TA1535, TA1537 and Escherichia coli WP2 uvrA the number of reversions is at least three times higher than the reversion rate of the vehicle control. - Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- Results of this mutagenicity assay show that under the experimental conditions reported, the test item did not induce gene mutations by frameshift or base-pair substitution in the genome of the tester strains used. Therefore, the test item is considered non-mutagenic in this bacterial reverse mutation assay.
- Executive summary:
An in vitro bacteria reverse mutation assay according to OECD 471 was conducted with the test item. The test item was dissolved in acetone. In the initial and confirmatory mutation tests the following concentrations were examined: ±S9: 5000, 1600, 500, 160, 50 and 16 μg/plate. Because of the noticed strong inhibition obtained in the confirmatory mutation test an additional, complementary pre-incubation test was carried out in the absence of exogenous metabolic activation and the following concentration levels were investigated: -S9: 16, 5, 1.6, 0.5, 0.16 and 0.05 µg/plate. In the initial, confirmatory mutation and complementary pre-incubation tests Salmonella typhimurium TA98, TA100, TA1535, TA1537 strains and Escherichia coli WP2 uvrA were investigated.
Five bacterial strains were used to investigate the mutagenic potential of the test item in independent experiments, in a plate incorporation test (experiment I, initial mutation test), in a pre-incubation test (experiment II, confirmatory mutation test) and because of the strong inhibitory effect obtained in the confirmatory mutation test, in an additional, complementary pre-incubation test. The initial and confirmatory mutation tests were conducted with and without metabolic activation (±S9), the complementary pre-incubation test was performed in absence of metabolic activation (-S9), only. In the performed experiments the concentrations, including the controls, were tested in triplicate (positive and negative controls were run concurrently). In the performed experiments all of the validity criteria, regarding the investigated strains, negative (vehicle) and positive controls, S9 activity and number of investigated analysable concentration levels were fulfilled. No substantial increases were observed in revertant colony numbers of any of the five test strains following treatment with the test item at any concentration level, either in the presence or absence of metabolic activation (±S9) in the performed experiments. Sporadic increases in revertant colony numbers compared to the vehicle control values mostly within the actual historical control data ranges were observed in both independently performed main experiments. However, there was no tendency of higher mutation rates with increasing concentrations beyond the generally acknowledged border of biological relevance in the performed experiments.In the initial mutation test inhibitory effects of the test item were not observed. In the confirmatory mutation test and as well as in the completing complementary pre-incubation test inhibitory effect of the test item was noticed in all strains examined. The cytotoxicity was indicated by affected background lawn development (absent, reduced or slightly reduced background lawn) and/or decreased revertant colony counts (absent revertants or revertants below historical control data and/or below the corresponding vehicle data ranges).
In the initial mutation test following plate incorporation procedure microdrops (colloid-chemical phenomenon) were noticed in all strains at the highest examined concentration of 5000 µg/plate, without and with addition of exogenous metabolic activation (±S9). The obtained microdrops did not interfere with the scoring of the colonies and evaluation of background lawn development in any case.
No microdrops or precipitate of the test item were observed on the plates in the examined bacterial strains at any examined concentration level (±S9) following the pre-incubation procedures.
The reported data of this mutagenicity assay show, that under the experimental conditions reported, the test item did not induce gene mutations by frameshift or base-pair substitution in the genome of the tester strains used. Therefore, the test item is considered non-mutagenic in this bacterial reverse mutation assay.
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2019-02-11 to 2019-03-18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Version / remarks:
- 2016
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- For cell lines:
- Absence of Mycoplasma contamination: yes
- doubling time: 12-14 h
- Modal number of chromosomes: 2n = 22
MEDIA USED
- Type and composition of media:
DME (Dulbecco’s Modified Eagle’s) medium supplemented with L-glutamine (2 mM) and 1 % of Antibiotic-antimycotic solution (containing 10000 NE/mL penicillin, 10 mg/mL streptomycin and 25 µg/mL amphotericin B) and heat-inactivated foetal bovine serum (final concentration 10 %) - Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9 : phenobarbital (PB) and β-naphthoflavone (BNF) induced rat liver
- concentration or volume of S9 mix and S9 in the final culture medium: The protein concentrations of the S9 batch used in the experiments were 34.8, 39.7 and 37.8 mg/mL - Test concentrations with justification for top dose:
- Based on a cytotoxicity pre-experiment, the concentration ranges for the main study were chosen as follows:
4/24 h treatment/sampling time:
without S9-mix: 5, 10, 20 and 40 µg/mL test item
24/24 h treatment/sampling time
without S9-mix: 5, 10, 20 and 40 µg/mL test item
4/24 h treatment/sampling time
with S9-mix: 40, 60, 80 and 100 µg/mL test item - Vehicle / solvent:
- - Vehicle/solvent used: Acetone
- Justification for choice of solvent/vehicle: solubility of the test item and suitability with test system
- Justification for percentage of solvent in the final culture medium: according to the guideline - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- colchicine
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: duplicate
- Number of independent experiments : three
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding: 5 x 10^5 cells/dish
- Test substance added in medium
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 4 and 24 hours
- Harvest time after the end of treatment: 24 hours
FOR MICRONUCLEUS:
- Methods of slide preparation and staining technique used including the stain used: V79 cells were kept in fixative at 1-10°C before slides were prepared, but slides was not made on the day of harvest to ensure cells were adequately fixed. Cells were centrifuged and resuspended in a minimal amount of fresh fixative. Several drops of suspension were gently spread onto multiple clean, dry microscope slides. After the slides had dried the cells were stained for 25 minutes in filtered 10 % (v/v) Giemsa pH 6.8 buffer. The slides were rinsed, dried and mounted with coverslips.
- Number of cells spread and analysed per concentration: 1000 cells per culture (2000 cells per concentration)
- Criteria for scoring micronucleated cells: The number of cells containing micronuclei on each slide was noted. Observations were recorded on raw data sheets. A micronucleus was only recorded if it met the following criteria:
1) The micronucleus has the same staining characteristics and a similar morphology to the main nuclei, and
2) Any micronucleus present are separate in the cytoplasm or only just touching a main nucleus, and
3) micronuclei is smooth edged and smaller than approximately one third the diameter of the main nuclei.
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: relative increase in cell count (RICC)
- Rationale for test conditions:
- according to guideline
- Evaluation criteria:
- Providing that all acceptability criteria are fulfilled, a test item is considered to be clearly positive if, in any of the experimental conditions examined:
– at least one of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control,
– any of the results are outside the distribution of the laboratory historical negative control data (based 95% control limit),
– the increase of mutant frequency is concentration-related when evaluated with an appropriate trend test.
When all of these criteria are met, the test item is then considered able to induce chromosome breaks and/or gain or loss in this test system.
Providing that all acceptability criteria are fulfilled, a test item is considered clearly negative if, in all experimental conditions examined:
– none of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control,
– there is no concentration-related increase when evaluated with an appropriate trend test,
– all results are inside the distribution of the historical negative control data (based 95% control limit).
The test item is then considered unable to induce chromosome breaks and/or gain or loss in this test system.
In cases when the response is neither clearly negative nor clearly positive or in order to assist in establishing the biological relevance of a result, the data should be evaluated by expert judgment or further investigations. Performing a repeated experiment possibly using modified experimental conditions (e.g. concentration spacing, other metabolic activation conditions [i.e. S9 concentration or S9 origin]) could be useful. - Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Data on pH: pH in the test item treated cultures was between 7.5 - 7.7 in the main test
- Data on osmolality: osmolality in the test item treated cultures was between 334 - 343 mmol/kg in the main test
- Possibility of evaporation from medium: no
- Water solubility: not soluble in water
- Precipitation and time of the determination: no precipitation observed in main test
RANGE-FINDING/SCREENING STUDIES: yes
STUDY RESULTS
- Concurrent vehicle negative and positive control data : valid
For all test methods and criteria for data analysis and interpretation:
- Concentration-response relationship where possible : no - Conclusions:
- The test item is considered not genotoxic based on the results of the OECD 487 compliant micronucleus assay in vitro.
- Executive summary:
This study was performed to evaluate the clastogenic and aneugenic potential of the test item by its effects on the frequency of micronuclei in cultured V79 cell lines treated in the absence and presence of a rat liver metabolizing system according to OECD TG 487. The test item was dissolved in Acetone and the following concentrations were selected on the basis of cytotoxicity investigations made in a preliminary study (with and without metabolic activation using S9 mix of phenobarbital and β-naphthoflavone induced rat liver). In this experiment (both run in duplicate with concurrent negative and positive controls) at least 2000 cells were analyzed for micronucleus at concentrations and treatment (exposure)/sampling (expression) intervals given below, ranging from no or little to maximum (55 ± 5%survival) toxicity.
4/24 h treatment/sampling time, without S9 -mix: 5, 10, 20 and 40 µg/mL test item
24/24 h treatment/sampling time, without S9 -mix: 5, 10, 20 and 40 µg/mL test item
4/24 h treatment/sampling time, with S9 -mix: 40, 60, 80 and 100 µg/mL test item
In this In Vitro Mammalian Cell Micronucleus Test, the frequency of the cells with micronuclei did not show biologically and statistically significant increases compared to the concurrent and historical controls when the test item was examined in the absence and in the presence of metabolic activation, up to the cytotoxic concentrations.
There was no precipitation of the test item at any dose level tested. No biologically relevant changes in pH or osmolality of the test system were noted at the different dose levels tested.
In the concurrent negative and positive control groups the percentage of cells with micronuclei were in the historical control range. The positive controls Mitomycin C (0.8 µg/mL), Colchicine (0.15 and 0.03 µg/mL) and Cyclophosphamide (6.25 µg/mL) caused expected biologically relevant increases of cells with micronuclei compared to solvent and historical controls. Thus, the study is considered valid.
The test item, both with and without metabolic activation, did not induce breakage and /or chromosomal loss in Chinese Hamster lung cells under the test conditions. Therefore, the test item is considered as non-genotoxic with the micronocucleus test.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018-09-06 to 2018-10-16
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Version / remarks:
- 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell gene mutation test using the Hprt and xprt genes
- Target gene:
- hypoxanthine-guanine phosphoribosyl transferase enzyme locus (hprt)
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Remarks:
- Subline KI
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells: ECACC (European Collection of Cell Cultures)
MEDIA USED
- Type and identity of media including CO2 concentration if applicable:
Ham's F12 medium containing 10 % fetal bovine serum and incubated at 37 °C in a humidified atmosphere of 5 % CO2 in air
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Periodically 'cleansed' against high spontaneous background: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- phenobarbital and beta-naphthoflavone induced male rat liver S9
- Test concentrations with justification for top dose:
- Test item concentrations without S9: 40, 50, 60, 80, 90, 100, 110 µg/mL
Test item concentrations with S9: 60, 70, 80, 90, 100, 110,120 µg/mL
Test item concentrations were chosen based on pre-test results on cytotoxicity. - Vehicle / solvent:
- - Vehicle/solvent used: acetone
- Justification for choice of solvent/vehicle: recommended vehicle by the guideline. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
- Cell density at seeding: 5x10^6
DURATION
- Exposure duration: 5 h
- Expression time (cells in growth medium): 19 h
- Selection time (if incubation with a selection agent): 8 days
SELECTION AGENT: hypoxanthine
NUMBER OF REPLICATIONS: 2
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency - Evaluation criteria:
- Assay acceptance criteria
The test is considered valid, because:
• With the exception of a single culture in the absence of metabolic activation, all concurrent negative controls are within the 95% control limits of the distribution of the laboratory historical solvent control database.
• The mutant frequency in the negative (solvent) control cultures is within the range (min-max) of historical laboratory control data.
• The positive control chemicals induce a statistically significant and biologically relevant increase in mutant frequency. These increases are compatible with the historical control data base.
• Adequate number of cells and concentrations were analysable.
• Two experimental conditions with and without metabolic activation were tested.
• The highest concentration was adequate.
• The cloning efficiency of the negative controls is between the range of 60% to 140% on Day 1 and 70% to 130% on Day 8.
Evaluation of Results
the test item is considered to be clearly positive if, in any of the experimental conditions examined:
• at least one of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control,
• any of the results are outside the distribution of the laboratory historical negative control data (based 95% control limit),
• the increase of mutant frequency is concentration-related when evaluated with an appropriate trend test.
Providing that all acceptability criteria were fulfilled, the test item is considered clearly negative if:
• none of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control,
• there is no concentration-related increase when evaluated with an appropriate trend test,
• all results are compatible the distribution of the historical negative control data (based 95% control limit). - Statistics:
- Statistical analysis was done with SPSS PC+ software for the following data:
• mutant frequency between the negative (solvent) control group and the test item or positive control item treated groups.
• mutant frequency between the laboratory historical negative (solvent) control group and concurrent negative (solvent) control, the test item or positive control item treated groups.
The data was checked for a linear trend in mutant frequency with treatment dose using the adequate regression analysis by Microsoft Excel software. The heterogeneity of variance between groups was checked by Bartlett's homogeneity of variance test. Where no significant heterogeneity was detected, a one-way analysis of variance was carried out. If the obtained result was positive, Duncan's Multiple Range test was used to assess the significance of inter-group differences. Where significant heterogeneity was found, the normal distribution of data was examined by Kolmogorov-Smirnov test. In case of a none-normal distribution, the non-parametric method of Kruskal-Wallis one-way analysis of variance was used. If there was a positive result, the inter-group comparisons were performed using the Mann-Whitney U-test. - Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: none
- Effects of osmolality: none
- Evaporation from medium: no
- Precipitation: no
RANGE-FINDING/SCREENING STUDIES: yes - Conclusions:
- The test item was not mutagenic in this in vitro mammalian cell gene mutation test performed with Chinese hamster ovary cells according to OECD 476 TG.
- Executive summary:
The test item, dissolved in Acetone, was tested in a Mammalian Gene Mutation Test in CHO-K1 cells according to OECD 476. The following concentrations were selected on the basis of a pre-test on cytotoxicity with and without metabolic activation using S9 mix of phenobarbital and β-naphthoflavone induced rat liver and solubility of test item.
5-hour treatment period without S9-mix: 40, 50, 60, 80, 90,100 and 110 μg/mL
5-hour treatment period with S9-mix: 60, 70, 80, 90, 100, 110 and 120 μg/mL
In the performed Mutation Assay the concentration levels were chosen mainly based on the cytotoxicity. Phenotypic expression was evaluated up to 8 days following exposure. In both experimental parts, there were no biologically or statistically significant increases in mutation frequency at any concentration tested, neither in the absence nor in the presence of metabolic activation. There were no statistically and biologically significant differences between treatment groups compared to the concurrent and historical control groups and no dose-response relationships were noted. All values were within the range of the laboratory historical control data. There was no precipitation of the test item at any dose level tested. No biologically relevant changes in the osmolality of the test system were noted at the different dose levels tested. The measured pH of treatment solution was similar compared to the control values. The mutation frequency found in the solvent controls was in the range of historical laboratory control data. The concurrent positive controls Ethyl methanesulfonate (1.0 μL/mL) and 7,12-Dimethyl benzanthracene (20 μg/mL) caused the expected biologically relevant increases of cells with mutation frequency as compared to solvent controls and were compatible with the historical positive control data. Thus, the study is considered valid. The test item tested up to cytotoxic concentrations both without and with metabolic activation (S9 mix), did not induce increases in mutant frequency in this in vitro test in Chinese hamster ovary cells, when tested up to cytotoxic concentrations. It is concluded that the test item was not mutagenic in this in vitro mammalian cell gene mutation test performed with in Chinese hamster ovary cells.
Referenceopen allclose all
Table 1 summary of signs of cytotoxicity
Confirmatory Mutation Test |
||||||||||
Concentrations (µg/plate) |
Salmonella typhimurium |
Escherichia coli WP2 uvrA |
||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
|||||||
‑S9 |
+S9 |
‑S9 |
+S9 |
‑S9 |
+S9 |
‑S9 |
+S9 |
‑S9 |
+S9 |
|
5000 |
B0 |
SB << |
B0 |
B << |
B0 |
B▲ |
A |
B << |
B << |
‑ |
1600 |
B0 |
SB < |
B0 |
B << |
B0 |
SB▲ |
B0 |
B << |
B << |
‑ |
500 |
B << |
SB << |
B << |
SB << |
B0 |
SB |
B0 |
B▲ |
B << |
‑ |
160 |
B << |
‑ |
B << |
< * |
SB << |
‑ |
SB0 |
‑ |
SB << |
‑ |
50 |
B << |
‑ |
B << |
< * |
SB << |
‑ |
SB0 |
‑ |
<< |
‑ |
16 |
B << |
‑ |
B << |
< * |
SB << |
‑ |
SB0 |
‑ |
<< |
‑ |
Complementary Pre-Incubation Test |
||||||||||
Concentrations (µg/plate) |
Salmonella typhimurium |
Escherichia coli WP2 uvrA |
||||||||
TA98 |
TA100 |
TA1535 |
TA1537 |
|||||||
‑S9 |
+S9 |
‑S9 |
+S9 |
‑S9 |
+S9 |
‑S9 |
+S9 |
‑S9 |
+S9 |
|
16 |
B << |
|
B << |
|
B << |
|
B0 |
|
SB << |
|
5 |
<< |
|
SB < |
|
▲ |
|
B << |
|
‑ |
|
1.6 |
‑ |
|
< * |
|
‑ |
|
‑ |
|
‑ |
|
0.5 |
‑ |
|
‑ |
|
‑ |
|
‑ |
|
‑ |
|
0.16 |
‑ |
|
‑ |
|
‑ |
|
‑ |
|
‑ |
|
0.05 |
‑ |
|
‑ |
|
‑ |
|
‑ |
|
▲ |
|
A: No bacterial growth: absent revertant colonies and absent background lawn;
B0: Absent revertant colonies and reduced background lawn development;
B: Reduced background lawn development;
SB: Slightly reduced background lawn development;
SB0: Absent revertant colonies and slightly reduced background lawn development;
<< : Revertant colony numbers below the vehicle and historical control data ranges;
< : Revertant colony numbers within of the vehicle control range but below the historical control data ranges;
< * : Revertant colony numbers within of the vehicle control range but below the historical control data ranges; however considered as not inhibition, but being within the biological variability range of the applied test system;
▲: Revertant colony numbers lower than the revertant colony number of the vehicle control but within the historical control data ranges;
‑: No inhibition.
Cells with dark grey filling: The concentration was not tested for the corresponding strain.
Table 2 Summary Table of the Results of the Initial Mutation Test
Initial Mutation Test (Plate Incorporation Test) |
||||||||||||||||||||
Concentrations (mg/plate) |
Salmonella typhimurium tester strains |
Escherichia coli |
||||||||||||||||||
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
WP2 uvrA |
||||||||||||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|||||||||||
Mean values of revertants per plate Mutation rate (MR) |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Untreated Control |
12.7 |
0.97 |
21.0 |
1.21 |
72.3 |
0.84 |
95.0 |
0.97 |
10.0 |
1.07 |
12.3 |
1.28 |
6.3 |
1.06 |
6.7 |
1.18 |
35.0 |
1.14 |
42.3 |
1.15 |
DMSO Control |
17.0 |
1.00 |
22.7 |
1.00 |
– |
– |
91.3 |
1.00 |
– |
– |
11.0 |
1.00 |
6.0 |
1.00 |
6.7 |
1.00 |
– |
– |
43.0 |
1.00 |
Ultrapure Water Control |
– |
– |
– |
– |
74.0 |
1.00 |
– |
– |
16.7 |
1.00 |
– |
– |
– |
– |
– |
– |
39.0 |
1.00 |
– |
– |
Acetone Control |
13.0 |
1.00 |
17.3 |
1.00 |
85.7 |
1.00 |
98.0 |
1.00 |
9.3 |
1.00 |
9.7 |
1.00 |
6.0 |
1.00 |
5.7 |
1.00 |
30.7 |
1.00 |
36.7 |
1.00 |
5000 |
35.7 |
2.74 |
19.3 |
1.12 |
75.3 |
0.88 |
70.7 |
0.72 |
11.7 |
1.25 |
11.7 |
1.21 |
9.0 |
1.50 |
8.0 |
1.41 |
31.7 |
1.03 |
38.7 |
1.05 |
1600 |
18.7 |
1.44 |
19.7 |
1.13 |
78.7 |
0.92 |
110.0 |
1.12 |
7.7 |
0.82 |
9.7 |
1.00 |
8.3 |
1.39 |
8.7 |
1.53 |
32.7 |
1.07 |
39.7 |
1.08 |
500 |
13.7 |
1.05 |
16.0 |
0.92 |
67.3 |
0.79 |
88.0 |
0.90 |
8.3 |
0.89 |
8.3 |
0.86 |
7.3 |
1.22 |
9.0 |
1.59 |
39.7 |
1.29 |
41.0 |
1.12 |
160 |
12.7 |
0.97 |
18.7 |
1.08 |
64.7 |
0.75 |
90.0 |
0.92 |
11.3 |
1.21 |
12.0 |
1.24 |
6.7 |
1.11 |
5.3 |
0.94 |
32.0 |
1.04 |
39.0 |
1.06 |
50 |
14.0 |
1.08 |
16.3 |
0.94 |
62.0 |
0.72 |
88.7 |
0.90 |
10.3 |
1.11 |
12.0 |
1.24 |
7.0 |
1.17 |
5.3 |
0.94 |
31.3 |
1.02 |
39.7 |
1.08 |
16 |
18.3 |
1.41 |
22.7 |
1.31 |
65.3 |
0.76 |
96.3 |
0.98 |
10.3 |
1.11 |
10.3 |
1.07 |
6.3 |
1.06 |
6.3 |
1.12 |
40.0 |
1.30 |
37.0 |
1.01 |
NPD (4mg/plate) |
498.0 |
29.29 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
SAZ (2mg/plate) |
– |
– |
– |
– |
1397.3 |
18.88 |
– |
– |
965.3 |
57.92 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
9AA (50mg/plate) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
736.7 |
122.78 |
– |
– |
– |
– |
– |
– |
MMS (2mL/plate) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
1157.3 |
29.68 |
– |
– |
2AA (2mg/plate) |
– |
– |
1154.7 |
50.94 |
– |
– |
1306.7 |
14.31 |
– |
– |
157.0 |
14.27 |
– |
– |
123.7 |
18.55 |
– |
– |
– |
– |
2AA (50mg/plate) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
253.0 |
5.88 |
Table 3 Summary Table of the Results of the Confirmatory Mutation Test
Confirmatory Mutation Test (Pre-Incubation Test) |
||||||||||||||||||||
Concentrations (mg/plate) |
Salmonella typhimurium tester strains |
Escherichia coli |
||||||||||||||||||
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
WP2 uvrA |
||||||||||||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|||||||||||
Mean values of revertants per plate Mutation rate (MR) |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Untreated Control |
16.0 |
0.91 |
29.0 |
1.78 |
68.3 |
0.87 |
87.3 |
0.94 |
14.7 |
1.05 |
9.0 |
0.87 |
7.7 |
1.28 |
9.7 |
0.91 |
24.0 |
0.81 |
39.7 |
0.97 |
DMSO Control |
16.7 |
1.00 |
17.0 |
1.00 |
– |
– |
85.7 |
1.00 |
– |
– |
10.0 |
1.00 |
6.3 |
1.00 |
8.7 |
1.00 |
– |
– |
43.3 |
1.00 |
Ultrapure Water Control |
– |
– |
– |
– |
75.7 |
1.00 |
– |
– |
11.3 |
1.00 |
– |
– |
– |
– |
– |
– |
32.3 |
1.00 |
– |
– |
Acetone Control |
17.7 |
1.00 |
16.3 |
1.00 |
78.3 |
1.00 |
93.3 |
1.00 |
14.0 |
1.00 |
10.3 |
1.00 |
6.0 |
1.00 |
10.7 |
1.00 |
29.7 |
1.00 |
41.0 |
1.00 |
5000 |
0.0 |
0.00 |
11.3 |
0.69 |
0.0 |
0.00 |
11.3 |
0.12 |
0.0 |
0.00 |
7.0 |
0.68 |
0.0 |
0.00 |
2.7 |
0.25 |
10.3 |
0.35 |
41.3 |
1.01 |
1600 |
0.0 |
0.00 |
13.7 |
0.84 |
0.0 |
0.00 |
35.3 |
0.38 |
0.0 |
0.00 |
5.3 |
0.52 |
0.0 |
0.00 |
4.3 |
0.41 |
8.0 |
0.27 |
37.7 |
0.92 |
500 |
1.7 |
0.09 |
12.0 |
0.73 |
7.0 |
0.09 |
69.0 |
0.74 |
0.0 |
0.00 |
8.7 |
0.84 |
0.0 |
0.00 |
5.7 |
0.53 |
8.0 |
0.27 |
42.7 |
1.04 |
160 |
0.7 |
0.04 |
17.0 |
1.04 |
2.0 |
0.03 |
77.3 |
0.83 |
4.0 |
0.29 |
8.7 |
0.84 |
0.0 |
0.00 |
10.3 |
0.97 |
10.0 |
0.34 |
34.7 |
0.85 |
50 |
0.7 |
0.04 |
25.3 |
1.55 |
1.0 |
0.01 |
88.7 |
0.95 |
2.7 |
0.19 |
9.3 |
0.90 |
0.0 |
0.00 |
8.7 |
0.81 |
12.3 |
0.42 |
40.0 |
0.98 |
16 |
1.3 |
0.08 |
18.3 |
1.12 |
27.0 |
0.34 |
81.3 |
0.87 |
4.3 |
0.31 |
11.3 |
1.10 |
0.0 |
0.00 |
8.7 |
0.81 |
13.7 |
0.46 |
40.7 |
0.99 |
NPD (4mg/plate) |
546.7 |
32.80 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
SAZ (2mg/plate) |
– |
– |
– |
– |
840.0 |
11.10 |
– |
– |
845.3 |
74.59 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
9AA (50mg/plate) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
404.0 |
63.79 |
– |
– |
– |
– |
– |
– |
MMS (2mL/plate) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
824.0 |
25.48 |
– |
– |
2AA (2mg/plate) |
– |
– |
1253.3 |
73.73 |
– |
– |
1237.3 |
14.44 |
– |
– |
119.0 |
11.90 |
– |
– |
121.7 |
14.04 |
– |
– |
– |
– |
2AA (50mg/plate) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
342.7 |
7.91 |
Table 4 Summary Table of the Results of the Complementary Pre-Incubation Test
Complementary Pre-Incubation Test |
||||||||||||||||||||
Concentrations (mg/plate) |
Salmonella typhimurium tester strains |
Escherichia coli |
||||||||||||||||||
TA 98 |
TA 100 |
TA 1535 |
TA 1537 |
WP2 uvrA |
||||||||||||||||
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
-S9 |
+S9 |
|||||||||||
Mean values of revertants per plate Mutation rate (MR) |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Mean |
MR |
Untreated Control |
12.0 |
0.86 |
– |
– |
67.0 |
1.03 |
– |
– |
7.7 |
0.88 |
– |
– |
5.7 |
1.06 |
– |
– |
30.7 |
1.00 |
– |
– |
DMSO Control |
12.0 |
1.00 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
6.3 |
1.00 |
– |
– |
– |
– |
– |
– |
Ultrapure Water Control |
|
|
– |
– |
73.7 |
1.00 |
– |
– |
8.7 |
1.00 |
– |
– |
– |
– |
– |
– |
29.3 |
1.00 |
– |
– |
Acetone Control |
14.0 |
1.00 |
– |
– |
65.0 |
1.00 |
– |
– |
8.7 |
1.00 |
– |
– |
5.3 |
1.00 |
– |
– |
30.7 |
1.00 |
– |
– |
16 |
4.7 |
0.33 |
– |
– |
44.0 |
0.68 |
– |
– |
2.7 |
0.31 |
– |
– |
0.0 |
0.00 |
– |
– |
15.7 |
0.51 |
– |
– |
5 |
10.3 |
0.74 |
– |
– |
57.0 |
0.88 |
– |
– |
6.7 |
0.77 |
– |
– |
3.3 |
0.63 |
– |
– |
25.7 |
0.84 |
– |
– |
1.6 |
16.7 |
1.19 |
– |
– |
72.0 |
1.11 |
– |
– |
8.7 |
1.00 |
– |
– |
5.7 |
1.06 |
– |
– |
32.0 |
1.04 |
– |
– |
0.5 |
17.7 |
1.26 |
– |
– |
77.0 |
1.18 |
– |
– |
8.3 |
0.96 |
– |
– |
4.7 |
0.88 |
– |
– |
24.7 |
0.80 |
– |
– |
0.16 |
14.0 |
1.00 |
– |
– |
75.3 |
1.16 |
– |
– |
9.7 |
1.12 |
– |
– |
6.0 |
1.13 |
– |
– |
29.7 |
0.97 |
– |
– |
0.05 |
13.0 |
0.93 |
– |
– |
75.7 |
1.16 |
– |
– |
7.3 |
0.85 |
– |
– |
5.0 |
0.94 |
– |
– |
21.3 |
0.70 |
– |
– |
NPD (4mg/plate) |
526.7 |
43.89 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
SAZ (2mg/plate) |
– |
– |
– |
– |
846.7 |
11.49 |
– |
– |
1072.0 |
123.69 |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
9AA (50mg/plate) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
473.3 |
74.74 |
– |
– |
– |
– |
– |
– |
MMS (2mL/plate) |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
– |
1173.3 |
40.00 |
– |
– |
MR: Mutation Rate; NPD: 4-Nitro-1,2-phenylenediamine; SAZ: Sodium azide; 9AA: 9-Aminoacridine; MMS: Methyl methanesulfonate; 2AA: 2-aminoanthracene
Remarcs: Acetone was applied as vehicle for the test item, ultrapure water was applied as vehicle of the positive control substances SAZ and MMS and DMSO was applied as vehicle of NPD, 9AA and 2AA. The mutation rate of the test item and the untreated control is given referring to the acetone, the mutation rate of SAZ and MMS is given referring to ultrapure water and the mutation rate of NPD, 9AA and 2AA is given referring to the DMSO.
Table 1 Results of the micronucleus analysis: 4-hour treatment without S9-mix / 24-hour sampling time (1000 cells scored per replicate; n = 2)
Test Group |
Concentration |
Total MN cells scored |
Frequency of MN cells (%) |
Untreated control |
- |
13 |
0.7 |
Negative (solvent control) |
0.4 µL/mL |
15 |
0.8 |
Test item |
5 µg/mL |
15 |
0.8 |
10 µg/mL |
15 |
0.8 |
|
20 µg/mL |
13 |
0.7 |
|
40 µg/mL |
16 |
0.8 |
|
Colchicine |
0.15 µg/mL |
162 |
8.1** |
Mitomycin C |
0.8 µg/mL |
170 |
8.5** |
** = p < 0.01 to the concurrent negative control and to the historical control
Table 2 Results of the micronucleus analysis: 24-hour treatment without S9-mix / 24-hour sampling time (1000 cells scored per replicate; n = 2)
Test Group |
Concentration |
Total MN cells scored |
Frequency of MN cells (%) |
Untreated control |
- |
11 |
0.6 |
Negative (solvent control) |
0.4 µL/mL |
14 |
0.7 |
Test item |
5 µg/mL |
14 |
0.7 |
10 µg/mL |
12 |
0.6 |
|
20 µg/mL |
12 |
0.6 |
|
40 µg/mL |
13 |
0.7 |
|
Colchicine |
0.03 µg/mL |
201 |
10.1** |
Mitomycin C |
0.8 µg/mL |
176 |
8.8** |
** = p < 0.01 to the concurrent negative control and to the historical control
Table 3 Results of the micronucleus analysis: 4-hour treatment with S9-mix / 24-hour sampling time (1000 cells scored per replicate; n = 2)
Test Group |
Concentration |
Total MN cells scored |
Frequency of MN cells (%) |
Untreated control |
- |
13 |
0.7 |
Negative (solvent control) |
0.4 µL/mL |
15 |
0.8 |
Test item |
5 µg/mL |
13 |
0.7 |
|
10 µg/mL |
15 |
0.8 |
|
20 µg/mL |
17 |
0.9 |
|
40 µg/mL |
12 |
0.6 |
Cyclophosphamide |
6.25 µg/mL |
296 |
14.8** |
** = p < 0.01 to the concurrent negative control and to the historical control
Table 1 CHO/HPRT MUTAGENESIS ASSAY RESULTS MAIN MUTATION ASSAY/a, b, c and d (5-hour Treatment without S9-Mix)
NON |
SURVIVAL TO TREATMENT |
REL. POPU- |
TOTAL |
ABSOLUTE |
MUTANT |
|||
MEAN COLONY |
PERCENT |
|||||||
Untreated control a |
200.0 |
± |
3.00 |
102 |
100 |
6 |
100 |
6.00 |
Solvent control a |
196.0 |
± |
2.65 |
100 |
100 |
6 |
100 |
6.00 |
Pos. control |
48.3 |
± |
1.53 |
25 |
62 |
894 |
62 |
1441.94** |
TEST ITEM |
|
|||||||
40g/mL a |
180.7 |
± |
1.15 |
92 |
97 |
5 |
97 |
5.15 |
50g/mL a |
165.0 |
± |
2.00 |
84 |
97 |
6 |
97 |
6.19 |
60g/mL a |
157.7 |
± |
1.53 |
80 |
98 |
5 |
98 |
5.10 |
80g/mL a |
133.0 |
± |
1.00 |
68 |
97 |
5 |
96 |
5.21 |
90g/mL a |
116.0 |
± |
3.00 |
59 |
97 |
5 |
97 |
5.15 |
100g/mL a |
48.0 |
± |
1.00 |
24 |
97 |
7 |
97 |
7.22 |
110g/mL a |
36.0 |
± |
1.00 |
18 |
97 |
7 |
96 |
7.29 |
NON |
SURVIVAL TO TREATMENT |
REL. POPU- |
TOTAL |
ABSOLUTE |
MUTANT |
|||
MEAN COLONY |
PERCENT |
|||||||
Untreated control b |
201.0 |
± |
1.00 |
102 |
100 |
6 |
100 |
6.00 |
Solvent control b |
198.0 |
± |
1.73 |
100 |
100 |
6 |
100 |
6.00 |
Pos. control |
49.0 |
± |
1.00 |
25 |
62 |
904 |
62 |
1458.06** |
TEST ITEM |
|
|||||||
40g/mL b |
183.0 |
± |
2.00 |
92 |
97 |
5 |
97 |
5.15 |
50g/mL b |
164.7 |
± |
1.15 |
83 |
98 |
5 |
98 |
5.10 |
60g/mL b |
156.3 |
± |
2.08 |
79 |
98 |
5 |
98 |
5.10 |
80g/mL b |
134.0 |
± |
1.00 |
68 |
97 |
6 |
98 |
6.12 |
90g/mL b |
115.7 |
± |
2.08 |
58 |
97 |
5 |
97 |
5.15 |
100g/mL b |
45.7 |
± |
1.53 |
23 |
97 |
6 |
98 |
6.12 |
110g/mL b |
34.0 |
± |
1.00 |
17 |
97 |
7 |
97 |
7.22 |
NON |
SURVIVAL TO TREATMENT |
REL. POPU- |
TOTAL |
ABSOLUTE |
MUTANT |
|||
MEAN COLONY |
PERCENT |
|||||||
Untreated control c |
202.7 |
± |
2.31 |
101 |
100 |
6 |
100 |
6.00 |
Solvent control c |
200.7 |
± |
2.08 |
100 |
100 |
7 |
99 |
7.07 |
Pos. control |
50.3 |
± |
2.08 |
25 |
64 |
898 |
64 |
1403.13** |
TEST ITEM |
|
|||||||
40g/mL c |
181.7 |
± |
1.53 |
91 |
98 |
6 |
98 |
6.12 |
50g/mL c |
170.3 |
± |
1.53 |
85 |
99 |
5 |
98 |
5.10 |
60g/mL c |
158.3 |
± |
2.08 |
79 |
97 |
6 |
96 |
6.25 |
80g/mL c |
132.0 |
± |
1.00 |
66 |
97 |
5 |
97 |
5.15 |
90g/mL c |
120.3 |
± |
0.58 |
60 |
97 |
5 |
97 |
5.15 |
100g/mL c |
49.3 |
± |
1.15 |
25 |
97 |
5 |
96 |
5.21 |
110g/mL c |
34.3 |
± |
0.58 |
17 |
97 |
7 |
96 |
7.29 |
NON |
SURVIVAL TO TREATMENT |
REL. POPU- |
TOTAL |
ABSOLUTE |
MUTANT |
|||
MEAN COLONY |
PERCENT |
|||||||
Untreated control d |
202.0 |
± |
1.00 |
101 |
101 |
5 |
100 |
5.00 |
Solvent control d |
200.3 |
± |
1.53 |
100 |
100 |
7 |
100 |
7.00 |
Pos. control |
50.7 |
± |
2.08 |
25 |
65 |
926 |
64 |
1446.88** |
TEST ITEM |
|
|||||||
40g/mL d |
184.0 |
± |
1.00 |
92 |
98 |
5 |
98 |
5.10 |
50g/mL d |
169.0 |
± |
1.00 |
84 |
98 |
6 |
98 |
6.12 |
60g/mL d |
160.0 |
± |
1.00 |
80 |
97 |
5 |
97 |
5.15 |
80g/mL d |
132.3 |
± |
0.58 |
66 |
98 |
5 |
97 |
5.15 |
90g/mL d |
120.7 |
± |
1.53 |
60 |
97 |
5 |
97 |
5.15 |
100g/mL d |
48.0 |
± |
1.00 |
24 |
97 |
5 |
97 |
5.15 |
110g/mL d |
33.3 |
± |
0.58 |
17 |
97 |
8 |
97 |
8.25 |
a = parallel of first culture
b = parallel of first culture.
c = parallel of second culture
d = parallel of second culture.
abs.C.E. = Absolute Cloning Efficiency
EMS= Ethyl methanesulfonate
** = p < 0.01 to the concurrent negative control and to the historical control
Table 2 CHO/HPRT MUTAGENESIS ASSAY RESULTS MAIN MUTATION ASSAY/a, b, c and d (5-hour Treatment with S9-Mix)
NON |
SURVIVAL TO TREATMENT |
REL. POPU- |
TOTAL |
ABSOLUTE |
MUTANT |
|||
MEAN COLONY |
PERCENT |
|||||||
Untreated control a |
201.3 |
± |
2.08 |
106 |
103 |
5 |
99 |
5.05 |
Solvent control a |
190.3 |
± |
1.53 |
100 |
100 |
7 |
97 |
7.22 |
Pos. control |
122.7 |
± |
2.08 |
64 |
80 |
559 |
77 |
725.97** |
TEST ITEM |
|
|||||||
60g/mL a |
179.0 |
± |
1.00 |
94 |
99 |
5 |
96 |
5.21 |
70g/mL a |
175.0 |
± |
2.00 |
92 |
98 |
7 |
95 |
7.37 |
80g/mL a |
167.7 |
± |
1.53 |
88 |
97 |
8 |
94 |
8.51 |
90g/mL a |
157.7 |
± |
3.21 |
83 |
98 |
6 |
95 |
6.32 |
100g/mL a |
126.7 |
± |
1.15 |
67 |
97 |
5 |
94 |
5.32 |
110g/mL a |
77.0 |
± |
2.65 |
40 |
97 |
6 |
94 |
6.38 |
120g/mL a |
24.0 |
± |
1.00 |
13 |
97 |
5 |
94 |
5.32 |
NON |
SURVIVAL TO TREATMENT |
REL. POPU- |
TOTAL |
ABSOLUTE |
MUTANT |
|||
MEAN COLONY |
PERCENT |
|||||||
Untreated control b |
201.3 |
± |
2.08 |
105 |
101 |
5 |
100 |
5.00 |
Solvent control b |
191.3 |
± |
1.53 |
100 |
100 |
6 |
99 |
6.06 |
Pos. control |
122.3 |
± |
2.08 |
64 |
79 |
561 |
78 |
719.23** |
TEST ITEM |
|
|||||||
60g/mL b |
180.3 |
± |
0.58 |
94 |
97 |
5 |
96 |
5.21 |
70g/mL b |
176.7 |
± |
1.15 |
92 |
97 |
5 |
95 |
5.26 |
80g/mL b |
167.0 |
± |
2.00 |
87 |
97 |
8 |
96 |
8.33 |
90g/mL b |
155.7 |
± |
3.06 |
81 |
97 |
6 |
96 |
6.25 |
100g/mL b |
126.7 |
± |
1.53 |
66 |
97 |
5 |
95 |
5.26 |
110g/mL b |
75.0 |
± |
1.00 |
39 |
96 |
5 |
95 |
5.26 |
120g/mL b |
26.7 |
± |
1.53 |
14 |
97 |
7 |
96 |
7.29 |
NON |
SURVIVAL TO TREATMENT |
REL. POPU- |
TOTAL |
ABSOLUTE |
MUTANT |
|||
MEAN COLONY |
PERCENT |
|||||||
Untreated control c |
201.0 |
± |
1.73 |
106 |
100 |
6 |
99 |
6.06 |
Solvent control c |
189.7 |
± |
0.58 |
100 |
100 |
6 |
99 |
6.06 |
Pos. control |
120.3 |
± |
1.53 |
63 |
78 |
566 |
77 |
735.06** |
TEST ITEM |
|
|||||||
60g/mL c |
178.0 |
± |
2.00 |
94 |
98 |
5 |
97 |
5.15 |
70g/mL c |
171.0 |
± |
1.00 |
90 |
100 |
5 |
99 |
5.05 |
80g/mL c |
169.0 |
± |
1.00 |
89 |
99 |
7 |
98 |
7.14 |
90g/mL c |
158.3 |
± |
1.15 |
83 |
97 |
5 |
96 |
5.21 |
100g/mL c |
125.0 |
± |
1.00 |
66 |
97 |
5 |
96 |
5.21 |
110g/mL c |
71.7 |
± |
1.53 |
38 |
97 |
5 |
96 |
5.21 |
120g/mL c |
24.3 |
± |
1.15 |
13 |
97 |
5 |
96 |
5.21 |
NON |
SURVIVAL TO TREATMENT |
REL. POPU- |
TOTAL |
ABSOLUTE |
MUTANT |
|||
MEAN COLONY |
PERCENT |
|||||||
Untreated control d |
201.3 |
± |
0.58 |
106 |
100 |
5 |
100 |
5.00 |
Solvent control d |
190.3 |
± |
2.08 |
100 |
100 |
7 |
99 |
7.07 |
Pos. control |
121.3 |
± |
1.53 |
64 |
78 |
542 |
78 |
694.87** |
TEST ITEM |
|
|||||||
60g/mL d |
179.0 |
± |
2.00 |
94 |
98 |
5 |
97 |
5.15 |
70g/mL d |
172.0 |
± |
1.00 |
90 |
99 |
5 |
99 |
5.05 |
80g/mL d |
170.3 |
± |
0.58 |
89 |
98 |
7 |
97 |
7.22 |
90g/mL d |
158.7 |
± |
1.15 |
83 |
97 |
5 |
96 |
5.21 |
100g/mL d |
121.7 |
± |
1.53 |
64 |
97 |
5 |
96 |
5.21 |
110g/mL d |
71.0 |
± |
1.00 |
37 |
97 |
5 |
97 |
5.15 |
120g/mL d |
24.7 |
± |
1.15 |
13 |
97 |
6 |
97 |
6.19 |
a = parallel of first culture
b = parallel of first culture.
c = parallel of second culture
d = parallel of second culture.
abs.C.E. = Absolute Cloning Efficiency
EMS= Ethyl methanesulfonate
** = p < 0.01 to the concurrent negative control and to the historical control
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
In vitro bacterial reverse mutation assay (Ames), OECD 471
An in vitro bacteria reverse mutation assay according to OECD 471 was conducted with the test item. The test item was dissolved in acetone. In the initial and confirmatory mutation tests the following concentrations were examined: ±S9: 5000, 1600, 500, 160, 50 and 16 μg/plate. Because of the noticed strong inhibition obtained in the confirmatory mutation test an additional, complementary pre-incubation test was carried out in the absence of exogenous metabolic activation and the following concentration levels were investigated: -S9: 16, 5, 1.6, 0.5, 0.16 and 0.05 µg/plate.
In
the initial, confirmatory mutation and complementary pre-incubation
tests Salmonella typhimurium TA98, TA100, TA1535, TA1537 strains and
Escherichia coli WP2 uvrA were investigated.
Five bacterial strains were used to investigate the mutagenic potential
of the test item in independent experiments, in a plate incorporation
test (experiment I, initial mutation test), in a pre-incubation test
(experiment II, confirmatory mutation test) and because of the strong
inhibitory effect obtained in the confirmatory mutation test, in an
additional, complementary pre-incubation test. The initial and
confirmatory mutation tests were conducted with and without metabolic
activation (±S9), the complementary pre-incubation test was performed in
absence of metabolic activation (-S9), only. In the performed
experiments the concentrations, including the controls, were tested in
triplicate (positive and negative controls were run concurrently).
In the performed experiments all of the validity criteria, regarding the investigated strains, negative (vehicle) and positive controls, S9 activity and number of investigated analysable concentration levels were fulfilled .
No substantial increases were observed in revertant colony numbers of any of the five test strains following treatment with the test item at any concentration level, either in the presence or absence of metabolic activation (±S9) in the performed experiments. Sporadic increases in revertant colony numbers compared to the vehicle control values mostly within the actual historical control data ranges were observed in both independently performed main experiments. However, there was no tendency of higher mutation rates with increasing concentrations beyond the generally acknowledged border of biological relevance in the performed experiments.
In the initial mutation test inhibitory effects of the test item were not observed. In the confirmatory mutation test and as well as in the completing complementary pre-incubation test inhibitory effect of the test item was noticed in all strains examined. The cytotoxicity was indicated by affected background lawn development (absent, reduced or slightly reduced background lawn) and/or decreased revertant colony counts (absent revertants or revertants below historical control data and/or below the corresponding vehicle data ranges).
In the initial mutation test following plate incorporation procedure microdrops (colloid-chemical phenomenon) were noticed in all strains at the highest examined concentration of 5000 µg/plate, without and with addition of exogenous metabolic activation (±S9). The obtained microdrops did not interfere with the scoring of the colonies and evaluation of background lawn development in any case. No microdrops or precipitate of the test item were observed on the plates in the examined bacterial strains at any examined concentration level (±S9) following the pre-incubation procedures. The reported data of this mutagenicity assay show, that under the experimental conditions reported, the test item did not induce gene mutations by frameshift or base-pair substitution in the genome of the tester strains used. Therefore, the test item is considered non-mutagenic in this bacterial reverse mutation assay.
In vitro gene mutation assay in mammalian cells (HPRT), OECD 476
The test item, dissolved in Acetone, was tested in a Mammalian Gene Mutation Test in CHO-K1 cells according to OECD 476. The following concentrations were selected on the basis of a pre-test on cytotoxicity with and without metabolic activation using S9 mix of phenobarbital and β-naphthoflavone induced rat liver and solubility of test item.
5-hour treatment period without S9-mix: 40, 50, 60, 80, 90,100 and 110 μg/mL
5-hour treatment period with S9-mix: 60, 70, 80, 90, 100, 110 and 120 μg/mL
In the performed Mutation Assay the concentration levels were chosen mainly based on the cytotoxicity. Phenotypic expression was evaluated up to 8 days following exposure. In both experimental parts, there were no biologically or statistically significant increases in mutation frequency at any concentration tested, neither in the absence nor in the presence of metabolic activation. There were no statistically and biologically significant differences between treatment groups compared to the concurrent and historical control groups and no dose-response relationships were noted. All values were within the range of the laboratory historical control data. There was no precipitation of the test item at any dose level tested. No biologically relevant changes in the osmolality of the test system were noted at the different dose levels tested. The measured pH of treatment solution was similar compared to the control values. The mutation frequency found in the solvent controls was in the range of historical laboratory control data. The concurrent positive controls Ethyl methanesulfonate (1.0 μL/mL) and 7,12-Dimethyl benzanthracene (20 μg/mL) caused the expected biologically relevant increases of cells with mutation frequency as compared to solvent controls and were compatible with the historical positive control data. Thus, the study is considered valid. The test item tested up to cytotoxic concentrations both without and with metabolic activation (S9 mix), did not induce increases in mutant frequency in this in vitro test in Chinese hamster ovary cells, when tested up to cytotoxic concentrations. It is concluded that the test item was not mutagenic in this in vitro mammalian cell gene mutation test performed with in Chinese hamster ovary cells.
In vitro micronucleus assay in mammalian cells, OECD 487
This study was performed to evaluate the clastogenic and aneugenic potential of the test item by its effects on the frequency of micronuclei in cultured V79 cell lines treated in the absence and presence of a rat liver metabolizing system according to OECD TG 487.The test item was dissolved in Acetone and the following concentrations were selected on the basis of cytotoxicity investigations made in a preliminary study (with and without metabolic activation using S9 mix of phenobarbital and β-naphthoflavone induced rat liver). In this experiment (both run in duplicate with concurrent negative and positive controls) at least 2000 cells were analyzed for micronucleus at concentrations and treatment (exposure)/sampling (expression) intervals given below, ranging from no or little to maximum (55 ± 5%survival) toxicity.
4/24 h treatment/sampling time,without S9 -mix: 5, 10, 20 and 40 µg/mL test item
24/24 h treatment/sampling time,without S9 -mix: 5, 10, 20 and 40 µg/mL test item
4/24 h treatment/sampling time,with S9 -mix: 40, 60, 80 and 100 µg/mL test item
In this In Vitro Mammalian Cell Micronucleus Test, the frequency of the cells with micronuclei did not show biologically and statistically significant increases compared to the concurrent and historical controls when the test item was examined in the absence and in the presence of metabolic activation, up to the cytotoxic concentrations. There was no precipitation of the test item at any dose level tested. No biologically relevant changes in pH or osmolality of the test system were noted at the different dose levels tested.
In the concurrent negative and positive control groups the percentage of cells with micronuclei were in the historical control range. The positive controls Mitomycin C (0.8 µg/mL),Colchicine (0.15 and 0.03 µg/mL) and Cyclophosphamide (6.25 µg/mL) caused expected biologically relevant increases of cells with micronuclei compared to solvent and historical controls. Thus, the study is considered valid.
The test item, both with and without metabolic activation, did not induce breakage and /or chromosomal loss in Chinese Hamster lung cells under the test conditions. Therefore, the test item is considered as non-genotoxic with the micronocucleus test.
Justification for classification or non-classification
Classification,
Labelling, and Packaging Regulation (EC) No 1272/2008
The
available experimental test data are reliable and suitable for
classification purposes under Regulation (EC) No 1272/2008. Based on
available data on genotoxicity, the test item does not require
classification as mutagenic according to Regulation (EC) No 1272/2008
(CLP), as amended for the twelfth time in Regulation (EU) No 2019/521.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.